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Antigen processing for presentation by major histocompatibility complex class II (MHCII) 
molecules requires the latter to travel through the endocytic pathway together with its 
chaperons: the invariant chain (Ii) and DM. Nevertheless, the nature of the compartments 
where MHCII molecules travel to acquire peptides lacks definition regarding molecules 
involved in intracellular vesicular trafficking, such as Rab small GTPases. We aimed to 
define which Rab proteins are present during the intracellular transport of MHCII, DM, 
and Ii through the endocytic pathway on their route to the cell surface during dendritic 
cell (DC) maturation. We examined, by means of three-color confocal microscopy, the 
association of MHCII, DM, and Ii with Rab5, Rab7, Rab9, and Rab11 during the mat-
uration of bone marrow-derived or spleen DC in response to LPS as an inflammatory 
stimulus. Prior to the stage of immature DC, MHCII migrated from diffuse small cyto-
plasmic vesicles, predominantly Rab5+Rab7− and Rab5+Rab7+ into a pericentriolar 
Rab5+Rab7+Rab9+ cluster, with Rab11+ areas. As DC reached the mature phenotype, 
MHCII left the pericentriolar endocytic compartments toward the cell surface in Rab11+ 
and Rab9+Rab11+ vesicles. The invariant chain and MHCII transport pathways were not 
identical. DM and MHCII appeared to arrive to pericentriolar endocytic compartments of 
immature DC through partially different routes. The association of MHCII molecules with 
distinct Rab GTPases during DC maturation suggests that after leaving the biosynthetic 
pathway, MHCII sequentially traffic from typical early endosomes to multivesicular late 
endosomes to finally arrive at the cell surface in Rab11+ recycling-type endosomes. In 
immature DCs, DM encounters transiently MHCII in the Rab5+Rab7+Rab9+ compart-
ments, to remain there in mature DC.
Keywords: major histocompatibility complex class ii molecules, rab gTPases, h2DM, endocytic pathway, 
dendritic cells
Abbreviations: MHCII-PC, MHCII-related processing compartment; NSF, soluble N-ethyl maleimide sensitive factor; LRO, 
lysosome-related organelles; PEC, pericentriolar compartments and pericentriolar endocytic cluster (interchangeable).
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inTrODUcTiOn
The T cell antigen receptor of CD4(+) T cells recognizes peptides 
bound to major histocompatibility complex class II (MHCII) 
molecules on the surface of professional antigen-presenting cells 
(APC) that in primary immune responses are dendritic cells 
(DCs) (1). DCs initially exist in a steady state (immature), with 
mostly intracellular MHCII and little peptide diversity. Upon an 
inflammatory stimulus, in a few hours, DCs become activated 
and develop into mature DCs with MHCII located at the cell 
surface and loaded with a great variety of intracellularly acquired 
peptides as a result of antigen processing in endocytic compart-
ments (2, 3).
Major histocompatibility complex class II α and β chain 
biosynthesis and translocation into the endoplasmic reticulum 
is a process guided by the invariant chain (CD74, Ii), which 
assembles as trimers that permit MHCII assembly (4–7). The 
resulting MHCII-Ii complexes (up to nonamers) are transported 
through the Golgi apparatus and the trans-Golgi network (TGN) 
to the endocytic pathway, where Ii is progressively degraded and 
removed from MHCII by lysosomal hydrolases (8). Besides guid-
ing MHCII transport throughout the endocytic route, Ii prevents 
peptide binding to MHCII prior to reaching late endosomes 
(LE) by means of its class II-associated Ii peptide (CLIP) within 
residues ~84–105, which covers the MHCII peptide-binding 
groove (9–12). The final stage of MHCII within the endocytic 
pathway occurs in a late prelysosomal endocytic compartment, 
related to multivesicular endosomes, which constitutes the main 
processing compartment (MHCII-PC) (13, 14). Within this 
organelle, CLIP-loaded MHCII dimers meet DM, a non-classical 
MHCII-like molecule, which allows CLIP exchange for antigenic 
peptides onto the MHCII cleft. DM allows an MHCII to bind 
the best fitting peptide at reach (15), after which peptide-loaded 
MHCII leave the MHCII-PC en route to the cell surface, where 
they are recognized by CD4(+) T cells.
Intracellular traffic is a tightly regulated process with the par-
ticipation of several protein families, including soluble N-ethyl 
maleimide sensitive factor (NSF) attachment receptors (SNAREs), 
adaptors, coating proteins, small GTPases, and among others 
(16, 17). Of these, Rab and Arf subfamilies of GTPases regulate 
intracellular traffic, at least in part, by allowing the budding and 
targeting of transport vesicles and their cargo from donor to 
specific acceptor compartments (17–19). Rab GTPases and their 
effectors provide molecular switches that allow the organization 
of cell-membrane organelles into functional domains that are the 
sites of arrival and departure of targeted vesicles defined by the 
presence of particular Rabs and their effectors that coordinate 
interdomain transport (20–24). Some of the >60 mammalian 
Rab proteins belong to the endocytic pathway, of which the 
best characterized are Rab5, found mainly in clathrin-coated 
endocytic vesicles and early endosomes (EE), playing a role 
in receptor-mediated endocytosis and EE biogenesis (25–27). 
Rab7 is in LE and lysosomes (28–30) and, together with Rab5, 
is found in the transition from EE to LE (31). Rab9 is present in 
LE and the TGN (32, 33). Finally, Rab11 is characteristic of late 
recycling endosomes (RE) (21, 34). As yet, most knowledge about 
Rab GTPases comes from studies on polarized (epithelial) cells. 
Although a major recent publication has examined in detail the 
distribution and interactions of all Rab GTPases in DC (35), those 
studies were achieved in DC lines, with no reference to their func-
tions in different phases of DC differentiation and maturation 
and their relations to the antigen-processing machinery, such as 
MHCII and DM arrival to the MHCII-PC, as well as MHCII-Ii 
transport to the MHCII-PC and from there to the cell surface. 
Moreover, additional studies have examined the roles of Rab11 
and Rab43 in the phenomenon of cross-presentation for MHCI 
molecules (36, 37).
Many of the mechanisms of MHCII transport and peptide 
acquisition after antigen processing have been apparently defined 
in detail (38). However, several questions remain unanswered, 
particularly their temporal association with distinct Rab proteins 
that define particular endocytic compartments. MHCII-PC 
appears closely related to LE, also known as multivesicular bodies 
(MVBs), but its functional and morphological features resemble 
the so-called lysosome-related organelles, such as pigment cell 
melanosomes, endothelial cell Weibel–Palade bodies, platelet α 
granules, and CTL and natural killer cell lytic granules (39). The 
study of the association of Rab proteins with the major elements 
of the MHCII processing machinery during DC maturation is 
important to further define the nature of MHCII-PC among 
endocytic compartments, the sources and targets of MHCII-PC 
cargo, and the transport of MHCII and their chaperones along 
the endocytic route to the cell surface. Therefore, we examined 
the dynamics of MHCII, DM, and Ii temporary association with 
Rab small GTPases that regulate transport along the endocytic 
pathway during DC maturation in response to an inflammatory 
stimulus.
MaTerials anD MeThODs
Mice
B10.BR and C57/BL6j mice used in the experiments were 
originally purchased from Jackson Laboratories (Bar Harbor, 
ME, USA). B6-IAb-GFP mice have been described (40) and 
were a generous gift of Drs. Marianne Boes and Hidde Ploegh 
(Massachusetts Institute of Technology, Boston, MA, USA). 
Mice were bred and maintained at the Animal Facilities of the 
Department of Experimental Medicine, Faculty of Medicine, 
National University of Mexico (UNAM) or at CINVESTAV, 
Mexico City. The protocol was approved by the National 
Research and the Ethics Committees of the Coordinación de 
Investigación, Mexican Institute of Social Security. All experi-
ments were performed in vitro, and no manipulation was done 
to live mice. Four- to eight-week old mice were euthanized by 
quick immersion in CO2. Spleens were removed by postmortem 
laparotomy, and bone marrow was extracted from femurs and 
tibias by perfusion with saline through a 25-gauge needle in an 
insulin syringe.
Dendritic cells
For bone marrow-derived DC (BMDC), mouse bone marrow was 
placed in culture at a density of 5 × 105 cells/mL in RPMI 1640 
supplemented with 10% FBS, non-essential amino acids, 2 mM 
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l-glutamine, 100  U/mL penicillin, 100  µg/mL streptomycin, 
100  mM HEPES (all from HyClone, Thermo-Fisher Scientific, 
Logan, UT, USA), and 50 µM 2-mercaptoethanol (Sigma-Aldrich 
LLC., St. Louis, MO, USA) in the presence of mouse GM-CSF-rich 
culture supernatants from a GM-CSF-producing cell line (41) (a 
gift from Dr. Ralph Steinman, Rockefeller University, NY) or 
recombinant GM-CSF (Merck-Millipore, Darmstadt, Germany) 
for a 5-day period in bacteriological Petri dishes (Fisherbrand, 
Thermo-Fisher Scientific, Logan, UT, USA). At day 3 of cul-
ture, fresh GM-CSF-supplemented medium (80% of the initial 
volume) was added to the cultures. At day 5, DCs were highly 
enriched by means of antimouse CD11c-coated MACS (Miltenyi 
Biotech, Bergisch Gladbach, Germany) according to manufac-
turer’s instructions. At this point, DC (~40–60% of total cells) 
had a predominantly immature phenotype (MHCIIlow/CD86low). 
To induce DC maturation, 100 ng/mL of LPS from Salmonella 
typhimurium (ATCC 14,028  s, courtesy of Dr. Constantino 
López-Macías, UIMIQ, IMSS) (42) was added to CD11c+ cells 
from 5-day GM-CSF cultures and harvested after varying lengths 
of time. For some experiments, spleen DCs were isolated by 
means of antimouse CD11c-coated MACS and similarly cultured 
in the presence of LPS.
antibodies and reagents
Purified or biotinylated primary antibodies to MHCII (mouse 
H116.32 and 10.2.16 anti-IAk) were from hybridoma cul-
ture supernatants (a kind gift of Prof. Gunter Hämmerling, 
DKFZ, Heidelberg, Germany). Rat NIM-R4 was a courtesy of 
Dr. Leopoldo Santos-Argumedo, CINVESTAV, Mexico City. In-1 
(rat anti-Ii) was a gift of Dr. Norbert Koch. Rat anti-H2-DM, 
2C3A, was kindly donated by Dr. Lars Karlsson (Johnson & 
Johnson Pharmaceutical Research & Development, San Diego, 
CA, USA) or purchased from Pharmingen (San Jose, CA, USA). 
Rabbit antisera against Rab5a, Rab7, Rab9, and Rab11a were 
kind gifts from Dr. Marino Zerial (Max Planck Institute for Cell 
Biology and Genetics, Dresden, Germany). An additional anti-
Rab11a was custom made in sheep immunized with the 20mer 
peptide RIVSQKQMSDRRENDMSPSN, 174–193 (Invitrogen, 
Life Technologies, Carlsbad, CA, USA). This peptide, near the 
c-terminus, is unique to mouse Rab11a and has several sequence 
differences with any other known Rab proteins, including mouse 
Rab11b.
Second step reagents were Alexa 660-streptavidin (Molecular 
Probes, Life Technologies), TRITC- and FITC-antisheep, 
TRITC- and FITC-antigoat, FITC and TRITC-anti-rat, all from 
Jackson Immunoresearch Laboratories Inc., PA, USA. Although 
we mention here the fine specificities of the anti-Rab antisera 
(Rab5a, Rab11a), there is no evidence that the distinct Rab 
isoforms (i.e., Rab5a, b, c; Rab7a, B, etc.) play alternative roles in 
intracellular trafficking, as they only appear to differ in the types 
of cells expressing them and tissue distribution (43).
Microscopy
Untreated or LPS-treated DCs were harvested after varying 
lengths of time and placed in Alcian blue (Fluka, Sigma-
Aldrich LLC.)-treated glass slides and were allowed to attach 
by a 20-min incubation at 4°C, after which they were brought 
to 37°C for three more minutes. Slides were fixed and permea-
bilized in BD’s Cytofix/Cytoperm buffer (BD Biosciences, San 
Jose, CA, USA). Intracellular staining was achieved initially 
by the addition of a mixture of saturating dilutions of purified 
or labeled primary antibodies (e.g., MHCII, Rabn, DM, Ii) in 
different combinations, for 30 min, washed 3×, followed by the 
appropriate mixture of second reagents for each set of primary 
antibodies for another 30 min, after which they were washed 
3× in PBS. Afterward, cells were embedded in VectaShield 
(Vector Laboratories, Burlingame, CA, USA) and examined 
immediately or after storage at 4°C, protected from light, 
until analysis. For most experiments, images were acquired 
in a Carl Zeiss Axiovert Confocal Microscope equipped with 
argon 488, HeNe 543, and HeNe 633  nm lasers and 500–530 
BP, 565–615 BP, and 650 LP filters with LSM 510 software (Carl 
Zeiss, Oberkochen, Germany). Image analysis was achieved by 
means of the LSM 510 software and confirmed using ImageJ 
(v1.43u, NIH, USA, public domain) and finally processed 
for quality in Adobe Photoshop CS6 with no manipulations, 
except for color saturation, sharpness, exposure, contrast, and 
brightness in entire images. Additional confocal microscope 
analysis was performed using a Nikon Ti Eclipse confocal 
microscope equipped with an A1 imaging system, controlled 
by the proprietary software NIS Elements v.4.50. Imaging was 
performed using either a 20× (dry, NA 0.8), 60× (oil, NA 1.4), 
or 100× (oil, NA 1.5) objective lens, as specified in the text. Dyes 
were excited in a sequential mode using the built-in laser lines: 
403  nm (DyLight 405), 488  nm (GFP), 563  nm (Texas Red), 
and 633 nm (Allophycocyanin). Corresponding fluorescences 
were read in the following ranges: 425–475 nm (DyLight 405), 
500–550 nm (GFP), 570–620 nm (Texas Red), and 663–738 nm 
(Allophycocyanin).
Vesicle Distribution graphs
Early and late stages of MHCII and DM transport and their 
eventual encounter within the MHCII-PC were examined by 
means of vesicle distribution graphs to represent the distribu-
tion of MHCII and DM alone or in combination with Rab5 and/
or Rab7 along a line randomly traced through the cell. Pixel 
intensity information per fluorescence channel was extracted 
with ImageJ (v1.43u, NIH, USA, public domain). Each graph 
was generated from a minimum of three DCs at each stage 
of differentiation per experiment by means of Microsoft® 
Excel® (v14.3.9, Microsoft Corporation, Redmond, WA, USA). 
Additional analysis was performed in spleen IAb-GFP DCs 
stimulated with LPS and stained with antibodies against DM, 
and the rates of colocalization were examined sequentially by 
ImageJ and Prism softwares.
Flow cytometry
Dendritic cell suspensions were stained with the appropriate 
combination of primary and/or secondary antibodies as described 
and run in a FACSCalibur flow cytometer (Becton-Dickinson, 
San Jose, CA, USA). Data analysis was performed by means of the 
FlowJo software (TreeStar Inc., Ashland, OR, USA).
FigUre 1 | stages of dendritic cell (Dc) differentiation/maturation 
according to major histocompatibility complex class ii (Mhcii) 
distribution along the cytoplasm and cell surface. (a) Graphical 
representation of MHCII distribution in DC at three stages of maturation 
induced by LPS. The cells we call early (left) represent a phase prior to 
immature DC, are CD11c+, and have no detectable surface MHCII. 
Intermediate (middle) are typical immature DCs, whereas late (right) are 
mature DCs. (B) Two examples of cells for each stage and their variations, 
where MHCII in bone marrow-derived DC obtained from B6 mice were 
visualized in a confocal microscope (100×) in samples stained with 
antigen-presenting cell-labeled anti-IAb.
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resUlTs
The Distribution of Mhcii along the 
cytoplasm and cell surface allows the 
Distinction of Three stages of Dc 
Differentiation/Maturation
Given that at any time point of analysis, BMDC cultures contain 
a mixture of DC phenotypes ranging from pre-DC, immature 
(intracellular MHCII) to cells fully expressing MHCII on the cell 
surface (mature DC) (44), to avoid confusion and for better data 
interpretation we initially defined stages of DC differentiation/
maturation by MHCII distribution within the cell. After a 5-day 
culture in the presence of GM-CSF, BMDCs were cultured in the 
absence or presence of LPS for varying lengths of time and exam-
ined in a confocal microscope for MHCII (Figure 1; Figure S1 in 
Supplementary Material). Regardless of the length of culture with 
LPS before analysis, MHCII distribution identifies DCs as fol-
lows: the earliest cells (apparently pre-DCs) have small MHCII+ 
vesicles scattered along the cytoplasm, we refer to them as early 
DC. Intermediate (immature) DCs contain a large pericentriolar 
MHCII+ cluster and variable, usually small, amounts of MHCII 
in the periphery. Finally, mature DCs (referred here to as late) 
contain large amounts of MHCII in the periphery (mostly at the 
cell surface) and little or no MHCII in the cytoplasm. In samples 
not stained for MHCII (i.e., DM), no other marker allowed such 
distinctions, although in some cells Rab11 had a more or less 
distinctive pattern of distribution in each of these three stages 
(Figures 3 and 4). The majority of cells referred here to as early are 
found in 0–2 h cultures (before or shortly after addition of LPS), 
intermediate (2–6 h after LPS), and late (usually >6 h after LPS). 
Although spleen DCs showed similar patterns, the proportions of 
cells with the described phenotypes were more closely related to 
the length of culture in the presence of LPS (0–2 and 6 h).
During the initial Differentiation of Dc, 
Mhcii Merge from Diffuse cytoplasmic 
rab5+rab7− and rab5+rab7+ small 
Vesicles into a large Pericentriolar 
rab5+rab7+ cluster
During DC differentiation, after an inflammatory stimulus, 
MHCII leave the TGN en route to a late endocytic compart-
ment where, with the aid of DM, they bind peptides resulting 
from partial protein degradation (5, 45). Figure 2A and Figure 
S2 in Supplementary Material show that in early, unstimulated 
DC (pre-DC), the majority of MHCII were found in diffuse 
vesicles scattered along the cytoplasm predominantly colocal-
izing with Rab5 and Rab7. In intermediate (immature) DCs, 
MHCII progressively merge into a large pericentriolar cluster, 
which is heterogeneous, as in its inner part contains Rab5 and 
Rab7 almost completely overlapping, which is surrounded by an 
outer MHCII+ rim. At this stage, surface MHCII is absent or 
low. Finally, in late (mature) DCs, almost all MHCII have left the 
Rab5+Rab7+ pericentriolar endocytic cluster (PEC) toward the 
cell periphery, where they are densely expressed, probably both 
beneath and at the cell surface with no Rab5 and/or Rab7.
Presence of rab9 in the 
Mhcii+rab5+rab7+ Pec in immature Dc
To better characterize the MHCII+ compartments in early 
and immature DC, we examined their association with Rab9, a 
GTPase involved in the recycling of mannose 6-phosphate recep-
tors from LE to the TGN and necessary for MVB biogenesis (33, 
46). Figure 2B and Figure S2 in Supplementary Material show 
that MHCII+ vesicles in early DCs are Rab7+. At the intermedi-
ate state, these vesicles have merged with the PEC, which contains 
Rab9 with a pattern consisting of a central MHCII+Rab7+Rab9+ 
area surrounded by an MHCII+Rab7+Rab9− rim. In mature 
(late) DCs, MHCII are present mainly at the cell periphery, whereas 
Rab7 and Rab9 remain in the PEC with minimal or no MHCII. 
Of note, Rab7 colocalizes almost entirely with the LE-lysosomal 
marker Lamp1 (Figure 3). Thus, early transport of MHCII to the 
endocytic pathway occurs predominantly in small Rab5+Rab7+ 
cytoplasmic vesicles, a phenotype suggestive of rapidly recycling 
EE (47). In immature DC, most MHCII are found in a large PEC 
that contains Rab5, Rab7, and Rab9 heterogeneously distributed, 
suggesting that such PEC contains discrete, as yet uncharacter-
ized subcompartments. As expected, in mature DC, almost all 
MHCII but not Rab5, Rab7, and Rab9 are in the cell periphery.
FigUre 2 | Progression of major histocompatibility complex class ii (Mhcii) from cytoplasmic vesicles to pericentriolar compartments but not to 
the cell surface occurs in concert with rab5, rab7, and partial association with rab9. Three-color confocal microscope images (100×) of bone marrow-
derived dendritic cell from B6 mice untreated (early) or cultured in the presence of LPS (0.1 µg/mL) for at least 8 h and stained for (a) MHCII (antigen-presenting 
cells, APC), Rab5a (TRITC), and Rab7 (Alexa 488) or (B) MHCII (IAb, APC), Rab7 (TRITC), and Rab9 (Alexa 488). Images are representative of at least three 
independent experiments.
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late Transport of Mhcii to the cell 
surface in rab11+ Vesicles
Rab11 is a small GTPase involved in vesicle recycling from late 
and perinuclear endosomes to the plasma membrane (21, 34, 
48), making it a useful marker to additionally dissect MHCII 
transport, particularly at late stages. Figure 4 and Figure S3 in 
Supplementary Material depict the results of two experiments 
with different anti-Rab11 antisera showing that before and shortly 
after the addition of LPS (early DC), the majority of MHCII 
colocalized again only with Rab7 with some overlap with Rab11. 
At the intermediate stage, the PEC also contains Rab11 with a 
heterogeneous distribution, again suggestive of microdomains. 
In late DCs, the majority of MHCII are in the cell periphery 
forming an outer MHCII+Rab7−Rab11− rim, apparently in the 
extracellular side of the plasma membrane, which in some cells 
surrounds a homogeneous MHCII+Rab11+ internal rim, lying 
just beneath the cell surface. These results suggest that, during DC 
maturation, transport of MHCII from the PEC to the cell surface 
occurs in Rab11+ vesicles, a phenotype typical of late RE.
invariant chain Transport Does not 
Faithfully Match Mhcii Pathways
Next, we examined whether Ii transport had the same patterns 
as MHCII at each stage of DC maturation. This was important 
FigUre 3 | near complete colocalization of lamp1 with rab7 during dendritic cell (Dc) maturation. Association with major histocompatibility complex 
class II (MHCII) transport during early to intermediate DC toward pericentriolar compartments (PEC) but not from PEC to the cell surface during intermediate 
(immature) to late (mature) transition. Three-color confocal microscope images (100×) of bone marrow-derived DC from B10.BR mice, untreated (early) or cultured in 
the presence of LPS (0.1 µg/mL) for at least 8 h and stained for MHCII (IAk, H116.32 plus 10.2.16, followed by donkey anti-mouse-antigen-presenting cells), Rab7 
(TRITC), and Lamp1 (Alexa 488). Images are representative of at least three independent experiments.
6
Pérez-Montesinos et al. Rab GTPases, MHCII, and DM Transport
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 340
mainly because if the MHCII identified here were of biosynthetic 
origin, the MHCII+ vesicles in early but not in late DC should be 
Ii-positive. Figure 5A and Figure S3 in Supplementary Material 
show that in early DC, as expected, the Ii has a patchy cytoplasmic 
distribution, which is undistinguishable from MHCII in that it 
colocalizes with Rab7. At the intermediate state, Ii is mainly in 
the PEC and associated with Rab7 and Rab11, again similar to 
MHCII, but with some Ii+ vesicles scattered along the cytoplasm. 
In contrast, in mature DCs, Ii distribution has a complex pattern, 
whereas beneath the cell surface it is associated with Rab11, in 
the remaining cytoplasm, the Ii is diffusely distributed partly 
colocalizing with Rab11.
When DCs were stained simultaneously for MHCII, Ii, and 
Rab11 (Figure  5B; Figure S3 in Supplementary Material), in 
early DCs all MHCII appeared to colocalize with Ii, which, on 
the other hand, exceeded by far the amount of MHCII with 
abundant MHCII-free Ii-containing vesicles scattered along the 
cytoplasm minimally associated with Rab11. In immature DCs, 
MHCII, Ii, and Rab11 were in the PEC, with abundant free Ii+ 
vesicles in the cytoplasm. Finally, the most interesting picture 
was seen in late DC, where MHCII and Ii formed three layers: 
the most external one (at the cell surface) with only MHCII, the 
middle layer has both MHCII and Ii overlapping; and finally the 
most inner (cytoplasmic) layer contains free Ii. This observation 
suggests that the role of Ii in MHCII transport is more complex 
than currently thought.
Diverse Pathways for the arrival of h2DM 
and Mhcii to the Pec
A major event during MHCII antigen processing is MHCII 
interaction with the non-peptide binding, non-classical MHCII-
like molecule DM that allows peptide exchange onto the MHCII 
groove and appears to occur mainly in the MHCII-PC (15, 49, 
FigUre 4 | Transport of major histocompatibility complex class ii (Mhcii) from the pericentriolar compartment to the cell surface in association 
with rab11. Three-color confocal microscope images (100×) of bone marrow-derived dendritic cell either untreated (early) or cultured in the presence of LPS 
(0.1 µg/mL) for at least 8 h and stained for (a) Expt. 1. B10.BR mice, MHCII [IAk, antigen-presenting cells (APC)], Rab11 (TRITC), and Rab7 (Alexa 488), or (B) Expt. 
2. B6 mice, MHCII (IAb, APC), Rab7 (TRITC), and Rab11 (Alexa 488). Images are representative of at least three independent experiments.
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50). Hence, we next examined the kinetics of DM transport and 
association with MHCII during DC maturation. As in previous 
experiments, BMDCs or spleen DCs were cultured with LPS for 
different lengths of time and stained for H2-DM plus Rab5, Rab7, 
and/or Rab9. Figure 6A and Figure S4 in Supplementary Material 
show that in early DC, similar to MHCII, DM is diffusely located 
in small cytoplasmic vesicles but, unlike MHCII, many of these 
are negative for Rab5 and Rab7, with a few DM+ vesicles posi-
tive for either GTPases and a minimal fraction colocalizing with 
Rab9. In intermediate (immature) DCs, most DM is in the typical 
Rab5+Rab7+PEC that is also Rab9+ (Figure  6B; Figure S4 in 
Supplementary Material). As opposed to MHCII, in late DCs 
most DM remained in PEC at 6 h and even at 24 h (the last time 
point examined). The finding that DM reaches PEC in the stage 
of immature DC and its association therein with the same Rab 
proteins as MHCII strongly suggests that such PEC represents 
the main MHCII-PC. Moreover, the differences in the association 
of MHCII and DM with Rab5 and Rab7 in early DC suggest that 
DM and MHCII reach the MHCII-PC through diverse pathways.
Mhcii and DM Bulk association with rab5 
and rab7 during the initial stage of Dc 
Maturation Further suggests Diverse 
Pathways of Transport
To examine MHCII and DM transport and their eventual 
encounter within the PEC during DC differentiation/maturation 
in detail, we created graphs of the distribution of MHCII+ and 
FigUre 5 | Partial dissociation of major histocompatibility complex class ii (Mhcii) and ii chain transport, distribution, and association with rab11 
at different stages of dendritic cell maturation. Three-color confocal microscope images (100×) of bone marrow-derived dendritic cell from B6 mouse, either 
untreated (early) or cultured in the presence of LPS (0.1 µg/mL) for at least 8 h and stained for (a) Ii chain antigen-presenting cells (APC), Rab11 (Alexa 488), Rab7 
(TRITC) or (B) Ii chain APC, MHCII (Alexa 488), Rab11 (TRITC) images are representative of at least three independent experiments.
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DM+ vesicles, alone or in combination with Rab5 and/or Rab7, 
along a line traced across the cell from which we extracted the 
total pixel intensity per fluorescence channel. Figure 6C shows 
that in early DC, >90% of MHCII are present in Rab5+Rab7+ or 
Rab5+Rab7− vesicles (66.6% and 25%, respectively), suggestive 
of a transition from EE to LE. On the other hand, >50% of DM 
did not associate with any of these Rab proteins, with 25% of DM 
in LE (only with Rab7) and 16.1% with both Rab5 and Rab7 in 
early DCs. In intermediate DCs, the proportion of Rab5−Rab7−-
associated DM is similar to MHCII, which, as expected, is even 
greater in late DCs. In late DCs, most DM (86%) remains in PEC 
and nearly half MHCII is in Rab5−Rab7− areas.
Finally, we examined the colocalization of MHCII and DM 
in spleen DC at 0, 2 and 6 h, which, importantly, contain fewer 
cells of the early phenotype than BMDC. Figure 7 shows confocal 
microscope images of spleen DCs from IAb-GFP mice stained for 
DM with an APC or DyLight 405-labeled second reagent (shown 
as red). As seen, early DCs are less abundant than in BMDC, as 
MHCII (green) is clearly present at the cell surface (Figure 7A). 
Of the cells shown, only one has larger vesicles that appear to 
constitute the early phase of the PEC. Nevertheless, in most cells 
examined (including the four shown), both MHCII and DM were 
scattered in small vesicles along the cytoplasm, and although there 
was a significant colocalization of MHCII with DM in cytoplasmic 
vesicles, there was also a considerable number of MHCII+DM− 
and MHCII−DM+ vesicles (Figures  8A,B). At 2  h, most cells 
already contained a pericentriolar cluster (Figures  7B and 
8D,E) containing both DM and MHCII with varying degrees of 
colocalization (the image contains three cells with high level of 
colocalization and one with an apparently newly formed PEC). 
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FigUre 6 | continued
FigUre 6 | continued 
in early dendritic cells (Dcs), DM and major histocompatibility complex class ii (Mhcii) appear to arrive to Pec through diverse routes. Three-color 
confocal microscope images (100×) of bone marrow-derived DC from B6 mice, either untreated (early) or cultured in the presence of LPS (0.1 µg/mL) for at least 8 h 
and stained for (a) DM antigen-presenting cells (APC), Rab7 (TRITC), and Rab5 (Alexa 488) or (B) DM APC, Rab9 (Alexa 488), and Rab7 (TRITC). Images are 
representative of at least three independent experiments. (c) DCs from B6 mice processed as above were stained for MHCII (IAb, APC, top) or DM (APC, bottom) 
plus Rab5 and/or Rab7 for three-color confocal microscopy. The distribution of each color was analyzed on individual cell images (≥3 cells) to yield the fluorescence 
intensity per channel along a straight line, by means of Microsoft® Excel®. The percentage far red fluorescence intensity (shown as blue) per pixel (corresponding to 
either MHCII or DM) along a line traced across the cell was recorded by their coincidence or not with red fluorescence (Rab5) and/or green fluorescence (Rab7). 
Each graph includes data from at least three DCs at each stage of maturation per experiment. Images are representative of at least three independent experiments.
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Finally, by 6  h, the PEC contains predominantly DM, whereas 
most MHCII is in the cell periphery. As expected, there was no 
longer a significant colocalization of MHCII and DM, with only 
a few MHCII+DM+ vesicles (Figure 8C).
On the other hand, when we examined the degree of colocali-
zation in the pericentriolar area, at 0 h, it contained predomi-
nantly MHCII+DM+ dots, together with MHCII+DM− and 
MHCII−DM+ vesicles, that by 2 h were highly enriched for 
MHCII and by 6  h were mostly MHCII+DM+, with essen-
tially no MHCII or DM only vesicles (probably due to some 
MHCII remaining in the PEC). These findings suggest that 
the pericentriolar area in early and intermediate (immature) 
DCs is recruiting MHC and DM-containing vesicles, some of 
which appear to have merged. Moreover, by 2  h, essentially 
all MHCII vesicles have been recruited to the PEC and at 
6 h, the latter although statistically is still present in the PEC 
(Figure  8F), it has moved predominantly to the cell surface 
(Figure 7C).
It is possible that in the early spleen DCs, given their more 
advanced degree of differentiation, which occurred in vivo, the 
incipient PEC contains a higher number of MHCII+DM+ vesi-
cles than in the BM counterparts. Nevertheless, the results sug-
gest that early during DC differentiation/maturation, transport 
of MHCII and DM appears to occur through diverse vesicular 
pathways that merge at the intermediate stage (immature DC) 
prior to reaching the PEC (MHCII-PC), at the transition from EE 
to LE, where DM meets MHCII.
DiscUssiOn
The current studies were undertaken to examine the temporary 
association of MHCII, DM, and Ii chain with Rab GTPases 
distinctly expressed in early and late endocytic compartments in 
LPS-stimulated GM-CSF-induced BM-derived DCs by means of 
three or four-color confocal microscopy. The major findings of 
this work are (1) in BMDCs, prior to the stage of immature DC, 
MHCII merge from diffuse early Rab5+Rab7− and Rab5+Rab7+ 
endocytic vesicles onto a large late Rab5+Rab7+Rab9+ PEC, 
typical of immature DC, which also contains Rab11 spots. (2) 
The arrival of DM to PEC in BMDCs appears to occur through a 
pathway, which differs slightly from that of MHCII, to engage the 
endocytic route at a later stage than MHCII in immature DCs. 
(3) The association of MHCII with Rab11 beneath the cell surface 
in late (mature) DC suggests a role for recycling perinuclear 
endosomes in MHCII transport from the PEC to the cell surface. 
(4) Ii chain transport matches MHCII pathways only partially, 
as there are abundant MHCII-free Ii chain-containing vesicles, 
especially in early and late DCs.
Major histocompatibility complex class II biosynthesis and 
transport is aided by several accessory molecules that act as 
chaperones for MHCII en route to late endocytic processing 
compartments (6, 7, 51–55). Depending on the maturation state 
of DCs, MHCII-PC appears as a multilamellar (predominant in 
immature DC) or multivesicular LE (predominant in mature 
DC) (56). Similar to MVE, vesicular MHCII-PCs are compart-
mentalized by small intraluminal vesicles (ILVs), whereas in 
multilamellar MHCII-PCs ILVs are organized as concentric 
circles. ILVs carry cytoplasmic fluid immersed in the extracel-
lular fluid of the organelle lumen. Multivesicular MHCII-PC 
resembles MVB, whereas multilamellar MHCII-PC appears 
closer to lysosomes, probably containing MHCII destined for 
degradation. Regardless of that, there is general acceptance that 
MHCII-PC stands a step prior to lysosomes that are essentially 
terminal degradative organelles.
It has been suggested that instead of a dedicated MHCII-PC, 
peptide binding to MHCII takes place in a group of related MVBs 
(57). Analysis of the Rab GTPases present in MHCII+ organelles 
during DC maturation could contribute to a clearer picture. Very 
little is known about the relationship of MHCII and antigen pro-
cessing with Rab proteins; essentially that manipulation of Rab7 
(58) or Rab4 (59) alters MHCII-related antigen processing, but, to 
our knowledge, nothing else. Thus, our present observations add 
some clarification to the intracellular traffic of MHCII molecules. 
The PEC found in the cytoplasm of immature DCs appears to 
be a heterogeneous mixture of LE-related compartments, with 
the presence of Rab7, Rab9, and Lamp1. The presence of Rab5, 
which is known to be also present in MVB, suggests that such 
PEC receives cargo from EE. Moreover, in some cells, the PEC 
also contains Rab11, which is characteristic of late perinuclear 
RE (17), suggesting that such spots could be the points of depar-
ture for peptide-loaded MHCII molecules to the cell surface. 
Nevertheless, as parts of the PEC show a complete overlap of 
Rab5 with Rab7, Rab7 with Rab11, Rab7 with Rab9, and all of 
them with MHCII or DM, it suggests that at least at some point, 
all these molecules are simultaneously present at a single site. 
High-resolution electron microscopy studies have shown that in 
a late phase of DC maturation, MHCII-PCs fuse to form tubular 
structures (60). It is possible that the distinct vesicles in the PEC 
exchange their cargo through microtubules, although it would 
require analysis by ultra-high-resolution microscopy.
The current work also suggests that in early DCs (most likely 
immature DC precursors), DM and MHCII are transported 
FigUre 7 | continued
FigUre 7 | continued 
Major histocompatibility complex class ii (Mhcii) and DM intracellular 
transport to the Pec occur through diverse routes. Confocal 
microscopy images (60×) of spleen dendritic cells (DCs) from IAb-GFP mice 
before [(a), 0 h], 2 (B), or 6 h (c) after the addition of LPS (0.1 µg/mL). Each 
panel contains a panoramic with varying numbers of DCs, plus four digital 
enlargements of cells either from the same or from an alternative field, not 
shown in the panoramic. MHCII (GFP) is shown in green, whereas DM 
(antigen-presenting cells or DyLight 405) is shown in red. Enlargements are 
random and do not necessarily represent the actual size of each cell.
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differently to late endocytic compartments. MHCII is mainly 
transported in Rab5+Rab7− and Rab5+Rab7+ small vesicles, 
similar to those that carry exogenous proteins from the extracel-
lular media after phagocytosis or receptor-mediated endocytosis 
(25, 61–63). Rab5 is characteristic of clathrin-coated endocytic 
vesicles, EE and can be present in LE, which are Rab7+. Moreover, 
Rab7 is also present with Rab5 in a subfraction of rapidly matur-
ing EE that are targeted to LE (47). Prior to reaching the endocytic 
route, newly synthesized MHCII are briefly expressed on the cell 
surface (64–68). Although we could not detect MHCII on the 
surface of early DC, it would appear that MHCII are endocytosed 
in Rab5+ vesicles that fuse with EE. The presence of Ii in these 
early vesicles is consistent with the idea that such MHCII are 
of biosynthetic origin. On the other hand, the majority of DM 
arrived to the PEC in vesicles devoid of all the Rab proteins 
examined herein, except for a few Rab7+ or Rab9+ vesicles. 
MHCII and DM are unevenly distributed in the ILVs of MVB 
(69), such that interaction between them appears to occur only 
after complete MHCII-PC maturation, but how this organization 
is achieved is not completely clear.
Although the primary role of MHCII is to present peptides 
from exogenous sources, they often bind peptides of intracellular 
origin (70). To optimize binding of exogenous peptides, MHCII 
must be in a peptide-receptive state not prior to late endocytic 
compartments. This task is achieved in part by Ii, which binds to 
the MHCII peptide-binding groove through its CLIP region, pre-
venting peptide binding to MHCII from the biosynthetic pathway 
until EE (9). Ii is degraded stepwise by lysosomal proteases until 
the MHCII-PC, wherein only the CLIP remains bound. Once in 
MHCII-PC, DM interacts with MHCII-CLIP complexes, allow-
ing the release of CLIP. The finding that at least some DM and 
MHCII are delivered separately to late endocytic compartments 
could explain their spatial separation within the MVE.
Two final and probably relevant findings of the current studies 
are (1) the association of Rab11 and MHCII in the periphery of 
mature DC, just beneath the cell surface and (2) the unexpected 
distribution of MHCII-free Ii in late DC. As for the former, Rab11 
is typical of a subset of recycling pericentriolar endosomes, known 
to play important roles in exocytosis of a number of molecules in 
different cell types exocytosis (48, 71, 72), and even in late MHCI 
transport during cross-presentation (36). Thus, it is not surpris-
ing to have found this GTPase in association with MHCII in late 
stages of DC maturation, suggesting a role for Rab11+ vesicles in 
MHCII transport from MHCII-PC to the cell surface. This differs 
from the current notion that the limiting membrane of MVB or 
FigUre 8 | Dynamics of Mhc and DM intracellular transport during dendritic cell (Dc) maturation. Graphics showing the contents of diffuse cytoplasmic 
vesicles and in the pericentriolar endocytic cluster in DCs before (0 h) (a,D) and after culture in the presence of 0.1 µg/mL LPS (2 and 6 h) (B,c,e,F). The data were 
extracted from confocal microscope analysis of purified B6-IAb-GFP spleen DCs stained with anti-DM rat mAb plus antigen-presenting cells (APC)-goat antirat 
affinity purified antibodies. Relative values of fluorescence intensity for GFP (major histocompatibility complex class II, MHCII) and APC (DM) were quantified from 
ImageJ software and plotted and examined by means of the Prism 6 software. Statistical data (r2 and p) were obtained by means of the Pearson correlation test.  
A minimum of 50 cells with at least three GFP+, APC+ or GFP+APC+ dots per cell were examined, and data represent one of three independent experiments.
12
Pérez-Montesinos et al. Rab GTPases, MHCII, and DM Transport
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 340
MHCII-PC fuses in its entirety with the plasma membrane to 
deliver peptide-loaded MHCII (3, 38), whereas ILV-associated 
MHCII is either targeted to lysosomes for degradation or released 
as exosomes when MVB fuses with the plasma membrane (73). All 
late DCs examined here had MHCII associated only with Rab11 
in the cell periphery, whereas Rab5, Rab7, and Rab9 remained in 
the PEC that persisted after DC maturation, suggesting that the 
PEC does not fuse to the plasma membrane; instead, that, prior 
to expression at the cell surface, MHCII are contained in Rab11+ 
vesicles, most likely RE, beneath the plasma membrane. It has 
been shown that MHCII are transferred to the plasma membrane 
through tubular structures that appear to be elongations of the 
MHCII-PC or MVB, which associate with MHCII-enriched vesi-
cles in its most external regions (74), Rab11 could be part of such 
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structures. The PEC described here for immature DC contained 
Rab11+ patches, that in mature DC were not seen, but Rab11 
was, instead, in the periphery. This is consistent with the recently 
described analysis of Rab11a distribution in DC lines (35). If the 
images we show here represent tubular elongations of MHCII-PC 
or MVB, Rab5, Rab7, and Rab9 are absent in them.
Finally, the association of Rab11 with Ii in the periphery of late 
DC is intriguing, and it is unexpected too to find Ii-associated 
MHCII near the cell surface in mature DCs. As the In-1 mAb 
used here is directed at the Ii cytoplasmic tail, we do not know 
whether such Ii is a complete molecule or a partially degraded 
intermediate fragment. The Ii is known to perform some non-
MHCII-related functions, including association with MHCI 
(75, 76), CD1 (77), and CD44 (78), or as cytokine receptor for 
the macrophage inhibitory factor (79). Thus, it is possible that 
MHCII-free Ii chain is performing non-MHCII-related or any 
other, as yet, unknown chaperone function.
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